<?xml version="1.0" encoding="UTF-8"?>
<urlset
  xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
  xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://glpwatchdog.org/research/kpv-peptide-what-the-evidence-shows</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Watchdog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-08T00:00:00.000Z</news:publication_date>
      <news:title>KPV Peptide: What the Evidence Shows, and What FDA Found</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://glpwatchdog.org/research/aod-9604-what-the-evidence-shows</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Watchdog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-08T00:00:00.000Z</news:publication_date>
      <news:title>AOD-9604: What the Evidence Shows</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://glpwatchdog.org/research/amylin-analogs-petrelintide-eloralintide</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Watchdog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-08T00:00:00.000Z</news:publication_date>
      <news:title>Eloralintide and Petrelintide: The Amylin-Only Drugs in Phase 3</news:title>
    </news:news>
  </url>
</urlset>